SCHEMBL22784355

SCHEMBL22784355

CN1CCC(OC(=O)N2CCc3ccccc3C2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.55
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
CHRM3 P20309 2/20 0.51
CHRM4 P08173 1/20 0.51
CHRM5 P08912 1/20 0.51
CHRM1 P11229 1/20 0.51
KEAP1 Q14145 1/20 0.51
ABHD6 Q9BV23 1/20 0.51
MAPT P10636 2/20 0.50
TAAR1 Q96RJ0 1/20 0.50
SCN1A P35498 2/20 0.49
SCN2A Q99250 2/20 0.49
SCN3A Q9NY46 2/20 0.49
POLB P06746 2/20 0.48
HTT P42858 2/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13951292 0.93 CHRM4 (0.52) NOTUMKMT2AMEN1CHRM3CHRM4
SCHEMBL30132306 0.91 NOTUM (0.57) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL28825998 0.89 KEAP1 (0.61) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL22784496 0.85 NOTUM (0.50) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL14143372 0.83 ABHD6 (0.48) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL22785136 0.82 NOTUM (0.53) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL14877516 0.81 NOTUM (0.49) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL22784273 0.80 MEN1 (0.57) NOTUMKMT2AMEN1MAPTTAAR1
SCHEMBL14393093 0.80 ABHD6 (0.48) NOTUMKMT2AMEN1KEAP1ABHD6
SCHEMBL3717443 0.80 PRMT5 (0.52) NOTUMKMT2AMEN1KEAP1ABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020252222-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2020-12-17 WO disclosed